Speaker illustration

Doctor Yury Mareev

National Research Center for Therapy and Preventive Medicine, Moscow (Russian Federation)

Member of:

Heart Failure Association

Yura Mareev currently works at the National Medical Research Center for Preventive Medicine (Moscow) and Robertson Centre for Biostatistics, University of Glasgow (Glasgow). Yura does research in Cardiology.

Is atrial fibrillation an independent predictor of mortality in patients with heart failure and a reduced left ventricular ejection fraction?

Event: Heart Failure 2021 Online Congress

Topic: Epidemiology, Prognosis, Outcome

Session: Atrial Fibrillation and Device Therapy

Thumbnail

The long-term prognosis of patients with different types of heart failure admitted with decompensation in Russia

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic Heart Failure – Epidemiology, Prognosis, Outcome

Thumbnail

Carvedilol vs. metoprolol tartrate on mortality in patients with heart failure with a reduced ejection fraction and atrial fibrillation or sinus rhythm: a post-hoc analysis of COMET

Event: ESC CONGRESS 2017

Topic: Pharmacologic therapy

Session: Can we teach heart failure drugs new tricks?

Thumbnail

New clinical assessment scale - useful tool to analysis effect of treatment and prognosis of patients with heart failure

Event: HEART FAILURE 2016

Topic: Prognosis

Session: Prognosis

Thumbnail

Mortality and rehospitalization data from diuretic therapy with effective doses of oral torasemide and furosemide in treatment of patients with exacerbation of chronic heart failure (DUEL-CHF) trial

Event: HEART FAILURE 2016

Topic: Diuretics

Session: Diuretics and fluid status management

Thumbnail

This platform is supported by

logo Novo Nordisk